Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Understand why avoiding delays in retirement planning is crucial for your financial security. Make informed decisions for your future.
26,609 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A decade-long income lure from QYLD masks a sizable NAV erosion. The ETF's NAV has declined about 35% since its 2013 ...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
Rumors swirl around kendall jenner jacob elordi’s relationship, now tied to Justin and Hailey Bieber. This piece brea...
Ready to put $1,000 to work in AI? This beginner-friendly guide reveals a simple, diversified approach to the best st...
The iShares Semiconductor ETF surged in the first half of 2026, powered by AI infrastructure demand and a rebound in ...
Bond ETFs face a steady rate backdrop as the fed's benchmark rate 3.5%–3.75% holds. This guide breaks down what it me...
Investors are weighing Oklo's unique nuclear energy model against a bumpy ride in its stock. This guide breaks down t...
As July 2026 brings steady rates, households weigh HYSA against Treasury Bills for emergency funds. The decision hing...
Is Walmart stock a a good bet right now? This guide breaks down the facts: fundamentals, valuation, and practical ste...
Bumble stock surged after the dating app maker teased new AI-powered features and provided market context on growth. ...
When Goldman Sachs raises its dividend as advisory and underwriting fees rebound, investors take notice. This article...